Currently, there are 271.83M common shares owned by the public and among those 258.31M shares have been available to trade.
The company’s stock has a 5-day price change of -14.96% and 17.57% over the past three months. AFRM shares are trading -9.11% year to date (YTD), with the 12-month market performance up to 29.29% higher. It has a 12-month low price of $22.25 and touched a high of $73.34 over the same period. AFRM has an average intraday trading volume of 8.97 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -12.95%, -10.54%, and 34.70% respectively.
Institutional ownership of Affirm Holdings Inc (NASDAQ: AFRM) shares accounts for 67.20% of the company’s 271.83M shares outstanding.
It has a market capitalization of $17.38B and a beta (3y monthly) value of 3.69. The earnings-per-share (ttm) stands at -$1.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.90% over the week and 6.10% over the month.
Analysts forecast that Affirm Holdings Inc (AFRM) will achieve an EPS of -0.3 for the current quarter, -0.17 for the next quarter and -0.2 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.48 while analysts give the company a high EPS estimate of -0.48. Comparatively, EPS for the current quarter was -0.54 a year ago. Earnings per share for the fiscal year are expected to increase by 77.77%, and 267.78% over the next financial year.
Looking at the support for the AFRM, a number of firms have released research notes about the stock. JMP Securities stated their Mkt Outperform rating for the stock in a research note on December 20, 2024, with the firm’s price target at $78. Jefferies coverage for the Affirm Holdings Inc (AFRM) stock in a research note released on December 19, 2024 offered a Buy rating with a price target of $82. Wedbush was of a view on October 14, 2024 that the stock is Neutral, while Wells Fargo gave the stock Overweight rating on October 11, 2024, issuing a price target of $40- $52. Morgan Stanley on their part issued Equal-Weight rating on October 09, 2024.
